Clinical trial
Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)
NCT00316576 · University Hospital, Caen, Other · Terminated
Key facts
| NCT number | NCT00316576 |
|---|---|
| Title | Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA) |
| Official title | Evaluation of the Impact of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Development of Acute Renal Failure in Critically Ill Patients |
| Lead sponsor | University Hospital, Caen, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Kidney Failure, Acute, Critical Illness |
| Intervention type | Procedure |
| Interventions | Blood sampling for PCR |
| Enrollment | 160 |
| Start date | May 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 21, 2006 |
| Last update posted | Jan 17, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: